Member Info for EGTP

Correction to last ABDX up to 5 million ‘weekly’ tests capacity

DYOR

David 1951 - Medusa-19 have invested £22 mil in LFT manufacturing equipment with capacity understood up to 25 million AffiDX tests per week (possible assistance from ABDX with some components) over and above ABDX have individual ability in place to produce up to 5 million monthly tests, There is also understood to be additional capacity in place in the EU to produce a further 25 million tests weekly if demand requires

There was also some kind of tie in / connection for Medusa-19 with a Chinese manufacturer reported on this BB previously.

So potential investors would be wise to do the maths.

Over and above the imminent blockbuster AVA6000 update, I believe we should now expect a number of RNS updates over the next few weeks related to AffiDX production (so beg pardon in advance) only idiots would sell now IMO

DYOR

For the benefit of those just looking in, and who are buying in today

Medusa-19 were formed in April 2020 by boohoo founders Richard Hughes and Mahmud Kamani they have so far invested over £22 million in LFT manufacturing equipment (drop in the ocean for them) to profit from the worldwide marketing and distribution of the worlds most accurate Covid-19 Antigen test namely AffiDX rebranded as ‘Meduflow’ using their exclusive home use distribution agreement with Avacta.

The boo boo founders evidently had a lot of faith and insight, because not only was covid-19 in its infancy and seen by the majority to be just a brief pandemic in spring 2020, they’ve also demonstrated the patience of faith (not saint) to hold on so long resisting the temptation to profit quicker by distributing any one of other similar antigen tests that were brought to market before the avacta AffiDX

Why is this so ?

Well it’s clear Medusa had the vision and insight the majority didn’t, but the main reason is that they fully understood long in advance how good the Avacta product powered by novel 21st century tech namely ‘Affimers’

https://en.m.wikipedia.org/wiki/Affimer

Not only do Affimers work better than traditional antibodies, they can also be produced faster and cheaper, but above all tailored to work with and bind too just about every known virus, blood infection, and cancer cell.

How does this play out from here ?

Well medusa-19 will aggressively market the initial avacta AffiDX covid-19 antigen test pinpointing the fact Affimers (Avacta copyright) are the reason its so good, and I believe they will succeed in selling multiple billions of these tests to the EU, Uk and ROW over the next 2 to 5 possibly 10 years, helping control the spread of covid-19 and saving many many lives.

In doing so they’ll earn £billions themselves by exploiting Affimers, while Avacta earns a cool royalty per test (£1 / £2 is spoken of) so not a bad deal for Avacta which should more than finance all current pipeline products, and maybe dividends for its beloved holders

But there are other major benefits to Medusa-19 too, firstly they’ll build a collosal world wide data base which they can then sell other AffiDX range products too, as well as perhaps boo hoo products

But the other and possibly main reason - well these 2 Guys are both major avacta shareholders, and my guess is they see the current valuation of their holdings rising possibly 20 to 100 times over the next few years as a direct result of selling the AffiDx ‘Meduflow’ powered by Affimers (the antibody treatment of the future) to the world audience

Yes powerful stuff and definitely not rampy, because it’s true, and it’s also true to say this is the best investment opportunity on AIM

It’s been a case of the tortoise and the hare, and evidently torture for some holders, but the tortoise has got there in the end !

DYOR and Christmas best wishes

Was really impressed when this company first floated December 2020 so bought in £1, but then just had to take profit when it spiked to £1.30 as felt that was the limit at the time, turns out I called it right, and got lucky missing the drop after the dreadful DHSC news.

But since then Profits are up 120%, £8.5 mil now in the bank from the placing, with up to 60 (plus 90 ?) million annual manufacturing capacity for the Avacta Affidx and vatic Covid Antigen tests, and the other Avacta Affidx tests to be announced - Plus work for Medusa-19 ?

How much extra monthly Profit (above the 120% last 12 months) will this add at 50p maybe £1 per test ?

I’m also very confident the DHSC will pay their £8 mil bill with interest in the coming months. But that aside Current ABDX Market cap is just £28 million ?

The cash and tangible assets of this company are worth more than the current mkt cap alone !

DYOR

So one could surmise from this tweet that Agile Testing services joined at the hip to Medusa-19 expect to have HUA in place before 04/01/22

https://twitter.com/lee_williams97/status/1471112795878047744?s=21

DYOR

Looks like Jupiter could be into a winner there code junkie - at least off set their avacta losses

https://twitter.com/lee_williams97/status/1471112795878047744?s=21

For anyone new or just looking in, what’s happening here is revolutionary check out ‘Affimers’ on Wikipedia, this company is well financed has multiple up coming world beating product lines, partnerships and projects with state of the art tech that will in my opinion re-write science

With AV6000 dose escalation and HUA for the worlds best covid-19 self test just around the corner, plus what Medusa-19 are doing, this is undoubtably the investment opportunity of a lifetime - nothing else on AIM touches it

DYOR

No reason why this shouldn’t now recover to at least 49p before any news once the final placing flips clear off - decent volume last few days, finance issue now cleared, major orders in the pipeline, already 120% up profit wise last 12 months, what’s not to like ?

DYOR

Yes that sums it happydays2u - current Abingdon mkt value is ludicrous, the assets alone are worth 30 to 35p

DYOR

Was really impressed when this company first floated December 2020 and bought in £1, but then just had to take profit when it spiked to £1.30 as felt that was the limit at the time, turns out I called it right, and got lucky missing the drop after the dreadful DHSC news.

But since then Profits are up 120%, with up to 5 million monthly manufacturing capacity for the Avacta Affidx Antigen test, plus other Affidx tests to be announced plus Vatic ? Plus Medusa-19 ?

How much extra monthly Profit does this add at 50p maybe £1 per test ?

And the most important question about the finance has now been resolved, and I’m very confident the DHSC will also pay their £8 mil bill with interest in the coming months

ABDX Market cap £30 million v ODX £49 Million ? ODX who’s profits and future outlook reduced to almost breakeven

DYOR

For anyone new or just looking in, what’s happening here is revolutionary check out ‘Affimers’ on Wikipedia, this company is well financed has multiple up coming world beating product lines, partnerships and projects with state of the art tech that will in my opinion re-write science

With AV6000 dose escalation and HUA for the worlds best covid-19 self test just around the corner, plus what Medusa-19 are doing, this is undoubtably the investment opportunity of a lifetime - nothing else on AIM touches it

DYOR

MMS calling for stock 3 v 1 - working large buy order by looks

Not sure this stock really needs anymore good news,
Profits were up 120% on the year previous, the finance question now resolved - they will be manufacturing up to 2 million tests for avacta monthly (plus Vatic ?) and they are about too / or have already been working with Medusa-19 (?) all very hush hush but very compelling, plus scale up for producing more diagnostic tests most likely under the avacta AffiDX range

I’m also pretty sure the asset value of Abingdon is higher than the current market cap (before gov debt paid) so all in all cheap as chips and only upside going forward

DYOR

Yes I thought so too pumpky in fact most of the trades today have to be forward sells at tiny profit or folk happy to sell at heavy losses when it’s pretty certain that we to me this placing will get bought off and sp will quickly rise

A list of the bigger players taking the placing could be quite excitable to many

I’m Sure I remember you from FRR pumpky ?

Yes the mms just took the opportunity to fill some orders

I must also take this opportunity to leap to my good friend Wyndrums defence. No I’m afraid his constant drivel deramps sp predictions and poorly informed future insights, do indeed have absolutely no effect on the SP here.

He’s just lonely so likes to talk.

Indeed the only reason the SP fell sharply into close was because Weak Avacta holders who simply believe AffiDX is the only Avacta product, and the Uk is the only target market were spooked because our waffling gormless Pm failed to once mention that testing was an important defence to covid and the new omicron variant - so the mms took the bid down and bingo !

But we need to appreciate this deluded right wing government is so far responsible for 39 U turns, so all hope for the Uk is not lost for AffiDX (keep in mind Medusa-19 still part of £3 billion NHS microbiology framework Lot 1 to supply AffiDX)

In the meantime avacta will shortly be announcing HUA, with other wow factors, allowing them and Medusa-19 to concentrate their efforts on the European and ROW home use market (currently not available in US)

As ever Do Your Own Research do not buy or keep holding this stock because of my feelings beliefs and convictions. I have what most would say is a large holding here, but I’m just a businessman and director of various who’s future insight brought me to avacta, not a swing trader, day trader or whatever my good friend Wyn makes out to be

Wyn thank you for the 4 letter name ‘xxxx’ you called me last time I’m sure it was complimentary, the ones reading and reacting to your posts must account for at least 1% of holders on here, so keep it up your close to surpassing Drew Ackerman

Avacta onwards and upwards HUA imminently and then we blow the doors off !

God bless all and Good Luck All

Yes great point MR Adventurous !

And in the very unlikely event this happened Avacta would rapidly produce a new affimer binders within weeks, and supply demand for the affimer reagents quicker and cheaper than any anti body reagents

DYOR

For the benefit of those just looking in, and who have bought in today

Medusa-19 were formed in April 2020 by boohoo founders Richard Hughes and Mahmud Kamani they have so far invested over £22 million in LFT manufacturing equipment (drop in the ocean for them) to profit from the worldwide marketing and distribution of the worlds most accurate Covid-19 Antigen test namely AffiDX rebranded as ‘Meduflow’ using their exclusive home use distribution agreement with Avacta.

The boo boo founders evidently had a lot of faith and insight, because not only was covid-19 in its infancy and seen by the majority to be just a brief pandemic in spring 2020, they’ve also demonstrated the patience of faith (not saint) to hold on so long resisting the temptation to profit quicker by distributing any one of other similar antigen tests that were brought to market before the avacta AffiDX

Why is this so ?

Well it’s clear Medusa had the vision and insight the majority didn’t, but the main reason is that they fully understood long in advance how good the Avacta product powered by novel 21st century tech namely ‘Affimers’ https://en.m.wikipedia.org/wiki/Affimerwould be.

Not only do Affimers work better than traditional antibodies, they can also be produced faster and cheaper, but above all tailored to work with and bind too just about every known virus, blood infection, and cancer cell.

How does this play out from here ?

Well medusa-19 will aggressively market the initial avacta AffiDX covid-19 antigen test pinpointing the fact Affimers (Avacta copyright) are the reason its so good, and I believe they will succeed in selling multiple billions of these tests to the EU, Uk and ROW over the next 2 to 5 possibly 10 years, helping control the spread of covid-19 and saving many many lives.

In doing so they’ll earn £billions themselves by exploiting Affimers, while Avacta earns a cool royalty per test (£1 / £2 is spoken of) so not a bad deal for Avacta which should more than finance all current pipeline products, and maybe dividends for its beloved holders

But there are other major benefits to Medusa-19 too, firstly they’ll build a collosal world wide data base which they can then sell other AffiDX range products too, as well as perhaps boo hoo products

But the other and possibly main reason - well these 2 Guys are both major avacta shareholders, and my guess is they see the current valuation of their holdings rising possibly 20 to 100 times over the next few years as a direct result of selling the AffiDx ‘Meduflow’ powered by Affimers (the antibody treatment of the future) to the world audience

Yes powerful stuff and definitely not rampy, because it’s true, and it’s also true to say this is the best investment opportunity on AIM

It’s been a case of the tortoise and the hare, and evidently torture for some holders, but the tortoise has got there in the end !

GLA and DYOR

Muller - it’s been made clear several times that the Avacta Affimer attaches itself to the spike protein of all covid-19 mutations and dominant variants, hence the reason it still had same near perfect detection rate for the delta variant - so there’s no logical reason for it not to detect Omicron either.

If you see https://www.lse.co.uk/rns/AVCT/affidx-lateral-flow-test-detects-delta-variant-p09616e51x5fqvk.html

‘AffiDX® antigen lateral flow test detects the Delta variant of the SARS-CoV-2 virus in clinical samples and, in this small study, outperformed two lateral flow antigen tests that are commercially available in Europe’

Yes appreciate some would like reassuring what’s been said over and over - but avacta are unfortunately not in the business of daily Ramps to temporarily uplift the SP, it’s only factual mileposts and actions that have already happened that get RNS treatment nowadays.

The next RNS next will most likely be HUA and a least a snippet of what Medusa-19 have been doing and will be doing going forward

DYOR

For anyone new or just looking in, what’s happening here is revolutionary check out ‘Affimers’ on Wikipedia, this company is well financed has multiple up coming world beating product lines, partnerships and projects with state of the art tech that will in my opinion re-write science

With HUA for the worlds best covid-19 self test just around the corner, plus what Medusa-19 are doing, this is undoubtably the investment opportunity of a lifetime - nothing else on AIM touches it

DYOR